UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MAY 15, 2006
OSI SYSTEMS, INC.
(EXACT NAME OF REGISTRANT SPECIFIED IN CHARTER)
CALIFORNIA | 000-23125 | 330238801 | ||
(STATE OR OTHER JURISDICTION OF INCORPORATION) |
(COMMISSION FILE NUMBER) | (IRS EMPLOYER IDENTIFICATION NO.) |
12525 CHADRON AVENUE
HAWTHORNE, CA 90250
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(310) 978-0516
(REGISTRANTS TELEPHONE NUMBER, INCLUDING AREA CODE)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
On May 15, 2006, we issued a press release announcing our earnings for the third quarter ended March 31, 2006. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein in its entirety by this reference.
On the following date, Spacelabs Healthcare, Inc., a subsidiary we recently formed to serve as a holding company for our medical monitoring and anesthesia systems businesses, issued a press release announcing its interim results for the nine months ended March 31, 2006. Spacelabs Healthcare is listed on the AIM of the London Stock Exchange, where it has traded since October 31, 2005 under the ticker symbol SLAB. A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein in its entirety by this reference.
We are furnishing the information contained in this Item 2.02 (including Exhibits 99.1 and 99.2). It shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 8.01. | Other Events. |
On September 27, 2005, we filed a Tender Offer Statement on Schedule TO relating to precommencement communications by us regarding the announcement of an exchange offer to be made by our affiliate, Spacelabs Healthcare, to issue options to purchase shares of common stock of Spacelabs Healthcare to certain of our employees, or the employees of our affiliates, in exchange for the cancellation of certain options to purchase shares of our common stock (which options could have been converted into options to purchase shares of a wholly-owned subsidiary of Spacelabs Healthcare). We have decided that it is our best interests to terminate the exchange offer at this point in time. As such, we do not intend to issue any additional communications in connection with the exchange offer.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit 99.1: | Press Release of OSI Systems, Inc., dated May 15, 2006. | |
Exhibit 99.2: | Press Release of Spacelabs Healthcare, Inc., dated March 16, 2006. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OSI SYSTEMS, INC. | ||||||||
Date: May 17, 2006 |
||||||||
By: |
/s/ Anuj Wadhawan | |||||||
Anuj Wadhawan | ||||||||
Chief Financial Officer |
EXHIBIT INDEX
Exhibit Number |
Description | |
99.1 | Press Release of OSI Systems, Inc., dated May 15, 2006. | |
99.2 | Press Release of Spacelabs Healthcare, Inc., dated May 16, 2006. |
Exhibit 99.1
For Further Information
OSI Systems Inc
12525 Chadron Ave
Hawthorne CA 90250
(310) 349 2237
Contact: Jeremy Norton Director of Investor Relations
OSI SYSTEMS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS
| Third Quarter Revenues increase 15% to $108.1 million; |
| Record revenues for the Security Group of $36.4 million; |
| Third Quarter Diluted Earnings Per Share of $0.06 vs. loss of $0.18 for comparable prior year period |
HAWTHORNE, Calif. (BUSINESS WIRE) May 15, 2006OSI Systems, Inc. (NASDAQ:OSIS) today announced results for the third quarter of fiscal 2006.
The Company reported revenues of $108.1 million for the third quarter of fiscal 2006, an increase of 15% from the $94.2 million reported for the third quarter of fiscal 2005. Net income for the third quarter of fiscal 2006 was $1.0 million, or $0.06 per diluted share, compared to a net loss of $2.9 million, or $0.18 per share, for the third quarter of fiscal 2005. The third quarter results included stock based compensation expenses of $1.5 million pre-tax, or $0.09 per diluted share due to the adoption of FAS 123(R) on July 1, 2005. Results for the third quarter of fiscal 2005 did not include stock-based compensation expenses.
For the first nine months of fiscal 2006, revenues increased by $42.8 million, or 15%, to $327.1 million, from $284.3 million for the comparable period of fiscal 2005. For the first nine months of fiscal 2006, the Company reported a net loss of $3.1 million or $0.20 per diluted share, compared to net income of $0.8 million or $0.05 per share for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, the Company incurred stock based compensation expenses of $4.1 million, or $0.25 per diluted share. Results for the first nine months of fiscal 2005 did not include stock-based compensation expenses.
OSI Chairman and CEO, Mr. Deepak Chopra stated, We are very pleased with the Companys operating results for the third quarter of fiscal 2006. The Security business had record revenues of $36.4 million and achieved profitability. We have received increased Cargo orders bringing the total Cargo backlog to approximately $43 million at the end of the third quarter. We also successfully launched our first product in the Automated Hold Baggage Screening market, the Rapiscan MVXR5000. We are committed to this market, as evidenced by the continuing development of our revolutionary solid state CT system that we call the RTT for Real Time Tomography. In the third quarter we announced an order for the RTT from the Manchester Airport Group for approximately $7 million with a customer option that if fully exercised, would bring the total contract value to approximately $40 million. We expect to see continued growth
for the Security business into fiscal 2007 in all product lines; Conventional, Automated Hold Baggage Screening and Cargo.
Mr. Chopra continued, In our Healthcare business we continued to see strong performance in our core products, monitoring and anaesthesia. For the first nine months of fiscal 2006 monitoring orders were up 18% globally with the strongest performance coming from the U.S., our largest market. We continue to capture our replacement cycle business in addition to gaining market share from our competitors. We expect to see continued organic growth for the business supplemented by acquisitions of complementary products and technologies. We remain on track to launch the anaesthesia product in the U.S. market in fiscal 2007.
Mr. Chopra concluded, Our Opto-Electronics business continues to show strong results, fueled by the strong economy and strength in growing Inter-Company sales to both to our Security and Healthcare businesses.
Guidance for the Six Months Ended June 30, 2006
The Company reiterates its previously published guidance for the second half of fiscal 2006 with revenue guidance of $231 million to $236 million compared to revenues of $219 million for the first half of fiscal 2006, and $194.9 million for the second half of fiscal 2005.
The Company anticipates that revenues and operating income will be higher in the fourth quarter when compared to the third quarter of fiscal 2006.
Segment Information
Security Business
The Security business reported revenues of $36.4 million for the third quarter of fiscal 2006, an increase of 26% from $29.0 million reported for the third quarter of fiscal 2005. Income from operations for the third quarter of fiscal 2006 was $1.2 million compared to a loss from operations of $4.1 million for the third quarter of fiscal 2005. The third quarter results included stock based compensation expenses of $0.2 million. Results for the third quarter of fiscal 2005 did not include stock-based compensation expenses.
For the first nine months of fiscal 2006, revenues increased by $2.8 million, or 3%, to $93.8 million, from $91.0 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, the business reported a loss from operations of $2.6 million, compared to a loss from operations of $3.0 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, the Security business incurred stock based compensation expenses of $0.7 million. Results for the first nine months of fiscal 2005 did not include stock-based compensation expenses.
Healthcare Business
The Healthcare business reported revenues of $49.4 million for the third quarter of fiscal 2006, compared to $47.8 million reported for the third quarter of fiscal 2005. Income from operations for the third quarter of fiscal 2006 was $1.1 million compared to $0.9 million for the third
quarter of fiscal 2005. The third quarter results included stock based compensation expenses of $0.6 million. Results for the third quarter of fiscal 2005 did not include stock-based compensation expenses.
For the first nine months of fiscal 2006, revenues increased by $17.2 million to $161.8 million from $144.6 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, income from operations increased by $2.2 million, or 27%, to $8.2 million, from $6.0 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, the Healthcare business incurred stock based compensation expenses of $1.1 million. Results for the first nine months of fiscal 2005 did not include stock-based compensation expenses.
Optoelectronics Business
The Optoelectronics business reported external revenues of $22.2 million for the third quarter of fiscal 2006, an increase of 28% from $17.3 million reported for the third quarter of fiscal 2005. Income from operations for the third quarter of fiscal 2006 was $3.6 million, compared to $2.0 million for the third quarter of fiscal 2005. The third quarter results included stock based compensation expenses of $0.1 million. Results for the third quarter of fiscal 2005 did not include stock-based compensation expenses.
For the first nine months of fiscal 2006, external revenues increased by $22.8 million, or 47%, to $71.5 million form $48.7 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, income from operations increased by $1.8 million, to $7.4 million from $5.6 million for the first nine months of fiscal 2005. For the first nine months of fiscal 2006, the Optoelectronics business incurred stock based compensation expenses of $0.4 million. Results for the first nine months of fiscal 2005 did not include stock-based compensation expenses.
Operating income was positively impacted by the continuing increase of Inter-Company sales to both the Security and Healthcare businesses. These sales are eliminated in consolidation; however, it does not impact our segment disclosure.
Conference Call Information
OSI Systems, Inc. will host a conference call today over the Internet beginning at 2:30 pm PT (5:30 pm ET), today to discuss these results. To listen, please log on www.fulldisclosure.com or www.osi-systems.com or www.fulldisclosure.com and follow the link that will be posted on the front page. A replay of the webcast will be available shortly after the presentation and will be archived on www.osi-systems.com. A telephonic replay of the call will also be available from 5:30pm PT on May 15th until May 22nd. The replay may be accessed by calling 888-286-8010 and entering the conference call identification number 33339020.
About OSI Systems, Inc.
OSI Systems Inc. is a Hawthorne, California based diversified global developer, manufacturer and seller of security and inspection systems, medical monitoring and anesthesia delivery products, and optoelectronic-based components, as well as a provider of engineering and manufacturing services. The Company has more than 30 years of experience in electronics engineering and manufacturing and maintains offices and production facilities located in more
than a dozen countries. OSI Systems, Inc. implements a strategy of expansion by leveraging its electronics and contract manufacturing capabilities into selective end product markets through organic growth and acquisitions. For more information on OSI Systems Inc. or any of its subsidiary companies, visit www.osi-systems.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Companys expectations, goals or intentions about the future, including, the Companys commitment to the Automated Hold Baggage Screening Market, the development of a solid state CT system and sale of such systems to the Manchester Airport Group, growth in the Security Groups product lines, organic growth in the Companys Healthcare businesses, acquisitions of complementary businesses, the launch of an anesthesia product line in the U.S. in fiscal 2007, and its guidance for the second half of its 2006 fiscal year, including predictions about future revenues and operating income. The actual results may differ materially from those described in or implied by any forward-looking statement. In particular, there can be no assurance that the Company will ultimately be successful in the Automated Hold Baggage Screening Market, that the Manchester Airport Group will exercise its option to purchase additional solid state CT systems,, that the Companys Healthcare operations will continue to experience organic growth, acquire related or complementary business, or successfully launch an anesthesia product line in the U.S. in fiscal 2007, or that future revenues and operating income will ultimately meet the Companys current expectations. Other important factors are set forth in our Securities and Exchange Commission filings. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
Three months ended March 31, | Nine months ended March 31, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Revenues |
$ | 108,092 | $ | 94,153 | $ | 327,100 | $ | 284,328 | ||||||||
Cost of goods sold |
65,019 | 60,975 | 201,932 | 180,908 | ||||||||||||
Gross profit |
43,073 | 33,178 | 125,168 | 103,420 | ||||||||||||
Operating expenses: |
||||||||||||||||
Selling, general and administrative |
33,805 | 30,165 | 100,738 | 80,551 | ||||||||||||
Research and development |
8,851 | 7,306 | 26,281 | 21,042 | ||||||||||||
Restructuring charges |
| | 800 | | ||||||||||||
Management retention bonus |
51 | 288 | 624 | 1,386 | ||||||||||||
Total operating expenses |
42,707 | 37,759 | 128,443 | 102,979 | ||||||||||||
Income (loss) from operations |
366 | (4,581 | ) | (3,275 | ) | 441 | ||||||||||
Other income (expense): |
||||||||||||||||
Interest income |
91 | 27 | 180 | 217 | ||||||||||||
Interest expense |
(236 | ) | (153 | ) | (1186 | ) | (306 | ) | ||||||||
Impairment of Equity investment |
| (182 | ) | | (182 | ) | ||||||||||
Gain on sale of marketable securities |
| | 349 | | ||||||||||||
Income (loss) before provision (benefit) for income taxes and minority interest |
221 | (4,889 | ) | (3,932 | ) | 170 | ||||||||||
Benefit for income taxes |
(820 | ) | (1,961 | ) | (1,816 | ) | (602 | ) | ||||||||
Income (loss) before minority interest |
1,041 | (2,928 | ) | (2,116 | ) | 772 | ||||||||||
Minority interest |
(30 | ) | | (976 | ) | 68 | ||||||||||
Net income (loss) |
$ | 1,011 | $ | (2,928 | ) | $ | (3,092 | ) | $ | 840 | ||||||
Earnings (loss) per share: |
||||||||||||||||
Basic |
$ | 0.06 | $ | (0.18 | ) | $ | (0.19 | ) | $ | 0.05 | ||||||
Diluted |
$ | 0.06 | $ | (0.18 | ) | $ | (0.20 | ) | $ | 0.05 | ||||||
Shares used in per share calculation: |
||||||||||||||||
Basic |
16,437,974 | 16,276,323 | 16,326,128 | 16,215,620 | ||||||||||||
Diluted |
16,765,508 | 16,276,323 | 16,326,128 | 16,589,734 | ||||||||||||
Condensed Consolidated Balance Sheets
(in thousands)
March 31, 2006 | June 30, 2005 | |||||
Cash and cash equivalents |
$ | 13,097 | $ | 14,623 | ||
Accounts receivable, net of allowance for doubtful accounts |
101,084 | 89,227 | ||||
Inventory |
116,619 | 107,441 | ||||
Other current assets |
32,451 | 26,382 | ||||
Total current assets |
263,251 | 237,673 | ||||
Non current assets |
114,143 | 109,447 | ||||
Total |
$ | 377,394 | $ | 347,120 | ||
Bank line of credit |
$ | 3,886 | $ | 15,752 | ||
Current portion of long term debt |
1,040 | 499 | ||||
Other current liabilities |
98,038 | 91,047 | ||||
Total current liabilities |
102,964 | 107,298 | ||||
Long-term debt |
5,414 | 4,852 | ||||
Other long-term liabilities |
17,844 | 11,343 | ||||
Minority interest |
8,748 | | ||||
Shareholders equity |
242,424 | 223,627 | ||||
Total |
$ | 377,394 | $ | 347,120 | ||
Segment Information
(in thousands)
Three months ended March 31, |
Nine months ended March 31, |
|||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Revenues - by Segment Group: |
||||||||||||||||
Security Group |
$ | 36,446 | $ | 29,037 | $ | 93,787 | $ | 91,017 | ||||||||
Healthcare Group |
49,429 | 47,793 | 161,799 | 144,597 | ||||||||||||
Optoelectronics and Manufacturing Group including intersegment revenues |
29,689 | 22,365 | 88,593 | 63,673 | ||||||||||||
Intersegment revenues elimination |
(7,472 | ) | (5,042 | ) | (17,079 | ) | (14,959 | ) | ||||||||
Total |
$ | 108,092 | $ | 94,153 | $ | 327,100 | $ | 284,328 | ||||||||
Operating income (loss) - by segment group: |
||||||||||||||||
Security Group |
$ | 1,230 | $ | (4,109 | ) | $ | (2,614 | ) | $ | (3,033 | ) | |||||
Healthcare Group |
1,063 | 873 | 8,159 | 5,972 | ||||||||||||
Optoelectronics and Manufacturing Group |
3,608 | 1,955 | 7,391 | 5,645 | ||||||||||||
Corporate |
(5,293 | ) | (3,259 | ) | (16,002 | ) | (7,685 | ) | ||||||||
Eliminations |
(242 | ) | (41 | ) | (209 | ) | (458 | ) | ||||||||
Total |
$ | 366 | $ | (4,581 | ) | $ | (3,275 | ) | $ | 441 | ||||||
SFAS 123R expenses included in segment operating income (loss) above is as follows:
Three months ended March 31, 2006 |
|||
Security Group |
$ | 241 | |
Healthcare Group |
620 | ||
Optoelectronics and Manufacturing Group |
129 | ||
Corporate |
551 | ||
Total |
$ | 1,541 | |
Nine months ended March 31, 2006 |
|||
Security Group |
$ | 689 | |
Healthcare Group |
1,076 | ||
Optoelectronics and Manufacturing Group |
407 | ||
Corporate |
1,911 | ||
Total |
$ | 4,083 | |
Exhibit 99.2
16 May 2006
SPACELABS HEALTHCARE, INC.
THIRD QUARTER RESULTS
OSI Systems, Inc. the majority shareholder of Spacelabs Healthcare, Inc. (Spacelabs or the Company) today announced its third quarter segment operating results for its healthcare business.
Third Quarter |
Third Quarter 2005 |
% | Nine Months 2006 |
Nine Months 2005 |
% | |||||||||||||
Revenue |
$ | 49.4m | $ | 47.8m | 3 | % | $ | 161.8m | $ | 144.6m | 12 | % | ||||||
Income from Operations excl. Stock Option Expenses |
$ | 1.7m | $ | 0.9m | 89 | % | $ | 9.3m | $ | 6.0m | 55 | % | ||||||
Stock Option Expenses |
$ | 0.6m | | | $ | 1.1m | | | ||||||||||
Income from Operations Incl. Stock Option Expenses |
$ | 1.1m | $ | 0.9m | 22 | % | $ | 8.2m | $ | 6.0m | 37 | % |
Highlights for Third Quarter of Fiscal 2006
| Company on-track to meet full year market earnings expectations; |
| Third quarter fiscal 2006 revenue increased by 3% to $49.4m with operating income increasing by 22% to $1.1m; |
| The gross margin for the first nine months of fiscal 2006 was 48%, a improvement of 2% compared to 46% for fiscal 2005; |
| Strong order bookings in monitoring up 18% globally through the first nine months of fiscal 2006, lead by the continued strong performance of the monitoring product line in the U.S market; |
| Company repaid approximately $6m in long term debt in third quarter of fiscal 2006; |
| Introduction of the UltraviewSL 2400 and 2600 wireless patent monitors in the third quarter of fiscal 2006; |
| On July 1, 2005 the Company began recording stock based compensation expense as required by FAS 123(R). The Company did not incur stock based compensation in Fiscal 2005. |
Chief Executive Officer of Spacelabs Healthcare Inc, Deepak Chopra, stated:
We are pleased with the operating results for the third quarter, particularly with the performance of our core products, monitoring and anaesthesia. For the first nine months, monitoring orders were up 18% globally with the strongest performance coming from the U.S., our largest market. We continue to capture our replacement cycle business in addition to gaining market share from our competitors. We expect to see continued organic growth for the business supplemented by acquisitions of complementary products and technologies. We remain on track to launch the anaesthesia product into the U.S. market in fiscal 2007.
The third quarter results for Spacelabs Healthcare are being reported as part of OSI Systems Healthcare business. As such, these results are segment results as defined by U.S. GAAP, and therefore differ from those that would be reported for Spacelabs Healthcare on a stand-alone basis. These results do not reflect certain corporate level costs and expenses relating to OSI Systems.
Conference Call Information
OSI Systems will host a conference call to discuss the third quarter operating results on Monday May 15th at 10:30pm GMT. To listen to a live or archived version of the conference call please go to www.SpacelabsHealthcare.com and follow the link from the home page.
- Ends -
For further information, please contact:
Spacelabs Healthcare Inc |
Tel: + 1 310 717 9182 | |
Deepak Chopra, Chief Executive Officer |
||
Jeremy Norton, Director of Investor Relations |
||
Collins Stewart Limited |
Tel: 020 7523 8000 | |
Tim Mickley / Philip Roe |
||
Hogarth Partnership |
Tel: 020 7357 9477 | |
Melanie Toyne-Sewell/Fiona Noblet/ Charlie Field |
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the companys expectations, goals or intentions about the future, including, but not limited to, statements regarding full year market earnings projections, future organic growth, acquisitions of complementary products and technologies, and launch of an anaesthesia product line in the U.S. in fiscal 2007. The actual results may differ materially from those described in or implied by any forward-looking statement. In particular, there can be no assurance that full year market earnings will meet current expectations, that the businesses will grow as expected, or that the launch of an anaesthesia product line in the U.S. will occur as anticipated. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.